Gene Expression Profiling Reveals Alterations of Specific Metabolic Pathways in Schizophrenia

Frank A. Middleton, Karoly Mirnics, Joseph N. Pierri, David A. Lewis, Pat Levitt

Research output: Contribution to journalArticle

326 Citations (Scopus)

Abstract

Dysfunction of the dorsal prefrontal cortex (PFC) in schizophrenia may be associated with alterations in the regulation of brain metabolism. To determine whether abnormal expression of genes encoding proteins involved in cellular metabolism contributes to this dysfunction, we used cDNA microarrays to perform gene expression profiling of all major metabolic pathways in postmortem samples of PFC area 9 from 10 subjects with schizophrenia and 10 matched control subjects. Genes comprising 71 metabolic pathways were assessed in each pair, and only five pathways showed consistent changes (decreases) in subjects with schizophrenia. Reductions in expression were identified for genes involved in the regulation of ornithine and polyamine metabolism, the mitochondrial malate shuttle system, the transcarboxylic acid cycle, aspartate and alanine metabolism, and ubiquitin metabolism. Interestingly, although most of the metabolic genes that were consistently decreased across subjects with schizophrenia were not similarly decreased in haloperidol-treated monkeys, the transcript encoding the cytosolic form of malate dehydrogenase displayed prominent drug-associated increases in expression compared with untreated animals. These molecular analyses implicate a highly specific pattern of metabolic alterations in the PFC of subjects with schizophrenia and raise the possibility that antipsychotic medications may exert a therapeutic effect, in part, by normalizing some of these changes.

Original languageEnglish (US)
Pages (from-to)2718-2729
Number of pages12
JournalJournal of Neuroscience
Volume22
Issue number7
StatePublished - Apr 1 2002

Fingerprint

Gene Expression Profiling
Metabolic Networks and Pathways
Schizophrenia
Prefrontal Cortex
Genes
Malate Dehydrogenase
Ornithine
Polyamines
Therapeutic Uses
Haloperidol
Ubiquitin
Oligonucleotide Array Sequence Analysis
Aspartic Acid
Alanine
Antipsychotic Agents
Haplorhini
Acids
Brain
Pharmaceutical Preparations
Proteins

Keywords

  • Aspartate
  • Citrate
  • Haloperidol
  • Malate
  • Microarray
  • Mitochondria
  • Neuroleptic
  • Ornithine
  • Polyamine
  • Prefrontal
  • Transcarboxylic acid
  • Ubiquitin

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Middleton, F. A., Mirnics, K., Pierri, J. N., Lewis, D. A., & Levitt, P. (2002). Gene Expression Profiling Reveals Alterations of Specific Metabolic Pathways in Schizophrenia. Journal of Neuroscience, 22(7), 2718-2729.

Gene Expression Profiling Reveals Alterations of Specific Metabolic Pathways in Schizophrenia. / Middleton, Frank A.; Mirnics, Karoly; Pierri, Joseph N.; Lewis, David A.; Levitt, Pat.

In: Journal of Neuroscience, Vol. 22, No. 7, 01.04.2002, p. 2718-2729.

Research output: Contribution to journalArticle

Middleton, FA, Mirnics, K, Pierri, JN, Lewis, DA & Levitt, P 2002, 'Gene Expression Profiling Reveals Alterations of Specific Metabolic Pathways in Schizophrenia', Journal of Neuroscience, vol. 22, no. 7, pp. 2718-2729.
Middleton, Frank A. ; Mirnics, Karoly ; Pierri, Joseph N. ; Lewis, David A. ; Levitt, Pat. / Gene Expression Profiling Reveals Alterations of Specific Metabolic Pathways in Schizophrenia. In: Journal of Neuroscience. 2002 ; Vol. 22, No. 7. pp. 2718-2729.
@article{0b7409d2cf264e99a21f672d7ff0e548,
title = "Gene Expression Profiling Reveals Alterations of Specific Metabolic Pathways in Schizophrenia",
abstract = "Dysfunction of the dorsal prefrontal cortex (PFC) in schizophrenia may be associated with alterations in the regulation of brain metabolism. To determine whether abnormal expression of genes encoding proteins involved in cellular metabolism contributes to this dysfunction, we used cDNA microarrays to perform gene expression profiling of all major metabolic pathways in postmortem samples of PFC area 9 from 10 subjects with schizophrenia and 10 matched control subjects. Genes comprising 71 metabolic pathways were assessed in each pair, and only five pathways showed consistent changes (decreases) in subjects with schizophrenia. Reductions in expression were identified for genes involved in the regulation of ornithine and polyamine metabolism, the mitochondrial malate shuttle system, the transcarboxylic acid cycle, aspartate and alanine metabolism, and ubiquitin metabolism. Interestingly, although most of the metabolic genes that were consistently decreased across subjects with schizophrenia were not similarly decreased in haloperidol-treated monkeys, the transcript encoding the cytosolic form of malate dehydrogenase displayed prominent drug-associated increases in expression compared with untreated animals. These molecular analyses implicate a highly specific pattern of metabolic alterations in the PFC of subjects with schizophrenia and raise the possibility that antipsychotic medications may exert a therapeutic effect, in part, by normalizing some of these changes.",
keywords = "Aspartate, Citrate, Haloperidol, Malate, Microarray, Mitochondria, Neuroleptic, Ornithine, Polyamine, Prefrontal, Transcarboxylic acid, Ubiquitin",
author = "Middleton, {Frank A.} and Karoly Mirnics and Pierri, {Joseph N.} and Lewis, {David A.} and Pat Levitt",
year = "2002",
month = "4",
day = "1",
language = "English (US)",
volume = "22",
pages = "2718--2729",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "7",

}

TY - JOUR

T1 - Gene Expression Profiling Reveals Alterations of Specific Metabolic Pathways in Schizophrenia

AU - Middleton, Frank A.

AU - Mirnics, Karoly

AU - Pierri, Joseph N.

AU - Lewis, David A.

AU - Levitt, Pat

PY - 2002/4/1

Y1 - 2002/4/1

N2 - Dysfunction of the dorsal prefrontal cortex (PFC) in schizophrenia may be associated with alterations in the regulation of brain metabolism. To determine whether abnormal expression of genes encoding proteins involved in cellular metabolism contributes to this dysfunction, we used cDNA microarrays to perform gene expression profiling of all major metabolic pathways in postmortem samples of PFC area 9 from 10 subjects with schizophrenia and 10 matched control subjects. Genes comprising 71 metabolic pathways were assessed in each pair, and only five pathways showed consistent changes (decreases) in subjects with schizophrenia. Reductions in expression were identified for genes involved in the regulation of ornithine and polyamine metabolism, the mitochondrial malate shuttle system, the transcarboxylic acid cycle, aspartate and alanine metabolism, and ubiquitin metabolism. Interestingly, although most of the metabolic genes that were consistently decreased across subjects with schizophrenia were not similarly decreased in haloperidol-treated monkeys, the transcript encoding the cytosolic form of malate dehydrogenase displayed prominent drug-associated increases in expression compared with untreated animals. These molecular analyses implicate a highly specific pattern of metabolic alterations in the PFC of subjects with schizophrenia and raise the possibility that antipsychotic medications may exert a therapeutic effect, in part, by normalizing some of these changes.

AB - Dysfunction of the dorsal prefrontal cortex (PFC) in schizophrenia may be associated with alterations in the regulation of brain metabolism. To determine whether abnormal expression of genes encoding proteins involved in cellular metabolism contributes to this dysfunction, we used cDNA microarrays to perform gene expression profiling of all major metabolic pathways in postmortem samples of PFC area 9 from 10 subjects with schizophrenia and 10 matched control subjects. Genes comprising 71 metabolic pathways were assessed in each pair, and only five pathways showed consistent changes (decreases) in subjects with schizophrenia. Reductions in expression were identified for genes involved in the regulation of ornithine and polyamine metabolism, the mitochondrial malate shuttle system, the transcarboxylic acid cycle, aspartate and alanine metabolism, and ubiquitin metabolism. Interestingly, although most of the metabolic genes that were consistently decreased across subjects with schizophrenia were not similarly decreased in haloperidol-treated monkeys, the transcript encoding the cytosolic form of malate dehydrogenase displayed prominent drug-associated increases in expression compared with untreated animals. These molecular analyses implicate a highly specific pattern of metabolic alterations in the PFC of subjects with schizophrenia and raise the possibility that antipsychotic medications may exert a therapeutic effect, in part, by normalizing some of these changes.

KW - Aspartate

KW - Citrate

KW - Haloperidol

KW - Malate

KW - Microarray

KW - Mitochondria

KW - Neuroleptic

KW - Ornithine

KW - Polyamine

KW - Prefrontal

KW - Transcarboxylic acid

KW - Ubiquitin

UR - http://www.scopus.com/inward/record.url?scp=0036550998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036550998&partnerID=8YFLogxK

M3 - Article

VL - 22

SP - 2718

EP - 2729

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 7

ER -